Control of induced elevated intraocular pressure
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 1, 2007
app pub date -
Aug 25, 2006
filing date -
Aug 25, 2005
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A variety of ocular diseases and conditions can be treated using corticosteroids or other compounds having glucocorticoid activity. A consequence of administration of such compounds is elevated intraocular pressure, which causes undesirable side-effects. The unwanted consequences of such elevated intraocular pressure may be prevented or treated through the administration of a steroid antagonist sufficient to counter the deleterious effect of the corticosteroid or other compound having glucocorticoid activity in the anterior chamber of the eye without countering the therapeutic effect of the treatment compound.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully